When will the FDA approve Intellia Therapeutics' lonvo-z?

Begins in 384 days · Jun 30, 12:00am EDT

$1,904 vol

ALL

Chance

Before July 2027

35%

Before July 2027

Before October 2027

Before October 2027

Before 2028

Before 2028

Before July 2027

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes. Sources from U.S. Food and Drug Administration., FDA, and Intellia Therapeutics.

Timeline and payout

Market openMar 24, 2026 · 10:00am EDT

Market closesAfter the outcome occurs

Projected payout30 minutes after closing

This market will close and expire early if the event occurs. Otherwise, it closes by Jun 30, 2027 at 11:59pm EDT.

SeriesKXFDAAPPROVALDATENTLA

EventKXFDAAPPROVALDATENTLA-LONV

MarketKXFDAAPPROVALDATENTLA-LONV-27JUL01

Insider trading is prohibited

The following are prohibited from trading this contract:

Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.